Brady Corp. A Stock
Brady Corp. A Stock
There is no change in the price for Brady Corp. A today.
The community is currently still undecided about Brady Corp. A with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 89 € shows a slightly positive potential of 4.71% compared to the current price of 85.0 € for Brady Corp. A.
Pros and Cons of Brady Corp. A in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Brady Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Brady Corp. A | 0.000% | 4.938% | 5.590% | 40.496% | 25.000% | 80.851% | 88.053% |
| Fti Consulting | -2.240% | -10.274% | -2.963% | -8.392% | -10.274% | -21.557% | 8.264% |
| ABM Industries Inc. | 0.000% | 1.932% | 8.763% | 4.455% | 16.575% | 2.427% | 6.566% |
| Exponent Inc. | - | 0.701% | 7.479% | -6.293% | -5.023% | -28.284% | -41.257% |
Comments
Brady (BRC) was upgraded by Sidoti from "neutral" to "buy". They now have a $103.00 price target on the stock.
Show more
Ratings data for BRC provided by MarketBeat
Brady (NYSE:BRC) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BRC provided by MarketBeat
Brady Co. (NYSE: BRC) was upgraded by analysts at Sidoti to a "strong-buy" rating.
Show more
Ratings data for BRC provided by MarketBeat
News
Zebra Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Zebra Technologies Corporation? Here are five stocks we like better.
- Record Q2 performance: Sales rose 20.4% year over year to more than $1.5 billion, while adjusted
PHINIA Q2 Earnings Call Highlights
Key Points
- Interested in PHINIA Inc.? Here are five stocks we like better.
- Second-quarter results improved: Revenue rose 5.6% year over year to $940 million, while adjusted EBITDA increased to
Medpace Q2 Earnings Call Highlights
Key Points
- Interested in Medpace Holdings, Inc.? Here are five stocks we like better.
- Medpace posted strong Q2 results, with revenue up 17.2% to $707.3 million and diluted EPS rising to $4.25